Dataset Information

Stability of Colloidal Iron Oxide Nanoparticles on Titania and Silica Support.

ABSTRACT: Using model catalysts with well-defined particle sizes and morphologies to elucidate questions regarding catalytic activity and stability has gained more interest, particularly utilizing colloidally prepared metal(oxide) particles. Here, colloidally synthesized iron oxide nanoparticles (Fe x O y -NPs, size ?7 nm) on either a titania (Fe x O y /TiO2) or a silica (Fe x O y /SiO2) support were studied. These model catalyst systems showed excellent activity in the Fischer-Tropsch to olefin (FTO) reaction at high pressure. However, the Fe x O y /TiO2 catalyst deactivated more than the Fe x O y /SiO2 catalyst. After analyzing the used catalysts, it was evident that the Fe x O y -NP on titania had grown to 48 nm, while the Fe x O y -NP on silica was still 7 nm in size. STEM-EDX revealed that the growth of Fe x O y /TiO2 originated mainly from the hydrogen reduction step and only to a limited extent from catalysis. Quantitative STEM-EDX measurements indicated that at a reduction temperature of 350 °C, 80% of the initial iron had dispersed over and into the titania as iron species below imaging resolution. The Fe/Ti surface atomic ratios from XPS measurements indicated that the iron particles first spread over the support after a reduction temperature of 300 °C followed by iron oxide particle growth at 350 °C. Mössbauer spectroscopy showed that 70% of iron was present as Fe2+, specifically as amorphous iron titanates (FeTiO3), after reduction at 350 °C. The growth of iron nanoparticles on titania is hypothesized as an Ostwald ripening process where Fe2+ species diffuse over and through the titania support. Presynthesized nanoparticles on SiO2 displayed structural stability, as only ?10% iron silicates were formed and particles kept the same size during in situ reduction, carburization, and FTO catalysis.

SUBMITTER: Krans NA

PROVIDER: S-EPMC7315821 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Stability of Colloidal Iron Oxide Nanoparticles on Titania and Silica Support.

Krans Nynke A NA van Uunen Dónal L DL Versluis Caroline C Dugulan Achim Iulian AI Chai Jiachun J Hofmann Jan P JP Hensen Emiel J M EJM Zečević Jovana J de Jong Krijn P KP

Chemistry of materials : a publication of the American Chemical Society 20200528 12

Using model catalysts with well-defined particle sizes and morphologies to elucidate questions regarding catalytic activity and stability has gained more interest, particularly utilizing colloidally prepared metal(oxide) particles. Here, colloidally synthesized iron oxide nanoparticles (Fe x O y -NPs, size ∼7 nm) on either a titania (Fe x O y /TiO2) or a silica (Fe x O y /SiO<su ...[more]

PMID: 32595267

Similar Datasets

Project description:BackgroundMesoporous silica (MPS) nanoparticles (NPs), which have a unique pore structure and extremely large surface area and pore volume, have received much attention because of their biomedical application potential. Using MPS NPs for biomedical devices requires the verification of their biocompatibility because the surface area of NPs is one of the most important determinants of toxicity, including the cellular uptake and immune response. We have previously reported that the cytotoxicity and inflammation potential of MPS NPs have been shown to be lower than those of general amorphous colloidal silica (Col) NPs in macrophages, but the low cytotoxicity does not guarantee high biocompatibility in vivo. In this study, we compared the in vivo immunotoxicity of MPS and Col NPs in the mouse model to define the effects of pore structural conditions of silica NPs.Materials and methodsBoth MPS and Col NPs (2, 20, and 50 mg/kg/day) were intraperitoneally administered in female BALB/c mice for 4 weeks, and clinical toxicity, lymphocyte population, serum IgG/IgM levels, and histological changes were examined.ResultsThere was no overt sign of clinical toxicity in either MPS- or Col-treated mice. However, MPS NPs led to significant increases in liver and spleen weight and splenocyte proliferation. Mice treated with MPS NPs showed altered lymphocyte populations (CD3(+), CD45(+), CD4(+), and CD8(+)) in the spleen, increased serum IgG and IgM levels, and histological changes. Despite slight changes in lymphocyte populations in the spleen, Col NPs did not alter other immunological factors.ConclusionThe results indicate that in vivo exposure to MPS NPs caused more damage to systemic immunity than that of Col NPs through the dysregulation of the spleen. The results for in vivo data are inconsistent with those for in vitro data, which show lower cytotoxicity for MPS NPs. These results suggest the importance of verifying biocompatibility both in vitro and in vivo during the design of new nanomaterials.

Dataset Information

Stability of Colloidal Iron Oxide Nanoparticles on Titania and Silica Support.

Publications

Stability of Colloidal Iron Oxide Nanoparticles on Titania and Silica Support.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure